RadheshyamNaik Author
Subjects of specialization
Affiliation
Philadelphia-negative chronic myeloproliferative neoplasms; , Retinoid, Senescence
Department of Translational Medicine & Therapeutics; Head, Department of Medical Oncology, Hematology and BMT, Bengaluru, India
RadheshyamNaik, Department of Translational Medicine & Therapeutics; Head, Department of Medical Oncology, Hematology and BMT, Bengaluru, India. DNB Resident, Department of Pathology, HealthCare Global (HCG) Hospital, Bengaluru, India
Research Article Open Access
Author(s): MVA Sireesha, Rajesh Kumar Ks, Kiran PK, Vinu Sarathy,Suhail Sayeed Mufti, Diganta Hazarika and RadheshyamNaik
Background: Lymphomas are a heterogenous group of lymphoproliferative disorders arising from B-cells, T-cells or Natural Killer (NK) cells, which are classified into Hodgkin and Non-Hodgkin Lymphoma. Hodgkin Lymphoma is categorised into Classical Hodgkin Lymphoma (CHL) and Non Classical types according to clinical, histomorphological, phenotypic and genotypic features. In India, the incidence of lymphoma has increased in the last decade and the increased incidence is found in patients of fifth and sixth decade. The etiology of HL remains unclear, usually arises denovo or seen to arise from Epstein-Barr viral infection. Analyzing expression of abundant EBV small nuclear RNA transcripts (EBER) in RS cells by RNA In Situ Hybridis... view moreĀ»